Lexology January 24, 2025
BRG

How payers, providers, and life sciences companies can navigate negotiations as the fates of the Inflation Reduction Act’s (IRA) drug pricing rules, the 340B program, and Medicare Advantage hang in the balance

On October 1, 2013, Healthcare.gov officially came online as part of the Affordable Care Act’s long-awaited rollout… and went down within two hours of launch. That first day, six total users signed up for health insurance on the new site.

This initial failure—not to mention the time it took for payers to effectively price insurance in the new market—exemplifies the implementation challenges policymakers and industry can face when a healthcare law transitions from words on a page to a complex reality.

In 2025, new regulations will be put...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Payer, Pharma, Pharma / Biotech, Provider
GenAI and the revolution of drug development
Amgen starts two critical late-stage trials for weight loss drug MariTide
Patient Access To Cheaper Biosimilar Drugs Varies Significantly Across Pharmacy Benefit Managers
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
'Not just adding another drug to your pharmacy': CAR T, explained

Share This Article